@booklet {61946,
	title = {Stimulating R\&D on Vaccines for AIDS, Tuberculosis, and Malaria: The Role of Tax Credits for Sales of Vaccines to Non-Profit Org},
	year = {2000},
	note = {Download PDF},
	month = {May 1, 2000},
	abstract = {The Vaccines for the New Millennium Act (HR 3812; SR 2132) includes both enhanced R\&amp;D tax credits and a tax credit for sales of vaccines to non{\textendash}profits and international organizations. The combination is likely to be effective. The enhanced R \&amp; D tax credit will provide an immediate benefit for firms doing research in the area. The tax credits for sales will provide incentives for firms to follow through by designing appropriate vaccines for the regions where the diseases are most deadly and will help increase accessability of any vaccines developed. There are several reasons why tax credits for sales of vaccines are an essential element of any package to promote vaccine R\&amp;D.},
	author = {Michael Kremer}
}
